Global Emerging Infectious Disease Diagnostics Market Size by Growth Rate, Business Challenges, Competitors, and Forecast 2033

Here's a comprehensive overview of the Global Emerging Infectious Disease Diagnostics Market based on the latest research report by Emergen Research, titled “Global Emerging Infectious Disease Diagnostics Market – Forecast to 2033”:

Get a sample of the report @ https://www.emergenresearch.com/request-sample/3695

? Market Overview

The global Emerging Infectious Disease Diagnostics market is projected to grow from an estimated USD 22.5 billion in 2024 to USD 47.3 billion by 2033, registering a Compound Annual Growth Rate (CAGR) of 8.60% during the forecast period.

 

? Market Drivers

  • Advancements in Diagnostic Technologies: Innovations such as CRISPR-based diagnostics, next-generation sequencing (NGS), and rapid point-of-care (PoC) testing are enhancing the speed and accuracy of disease detection.
  • Rising Prevalence of Infectious Diseases: The increasing incidence of diseases like COVID-19, Zika, and Ebola underscores the need for robust diagnostic solutions.
  • Government Funding and Public Health Initiatives: Increased investments in healthcare infrastructure and disease surveillance programs are propelling market growth.

 

? Market Segmentation

By Product & Service:

  • Reagents, Kits, and Consumables

By Type of Testing:

  • Laboratory Testing
  • Point-of-Care (PoC) Testing

By Technology:

  • Immunodiagnostics
  • DNA Microarray
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)

By Disease Type:

  • Hepatitis
  • HIV
  • Mosquito-borne Diseases
  • Human Papillomavirus (HPV)
  • Respiratory Infections
  • Sexually Transmitted Infections (STIs)
  • Gastrointestinal Infections

By Sample Type:

  • Blood
  • Serum
  • Other

By End User:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other

To know more about the report, click here @ https://www.emergenresearch.com/industry-report/emerging-infectious-disease-diagnostics-market

? Regional Outlook

  • North America: Dominates the market due to advanced healthcare infrastructure and high adoption of innovative technologies.
  • Europe: Significant growth driven by increased awareness and government initiatives promoting early disease detection.
  • Asia-Pacific: Expected to witness the fastest growth owing to a large patient pool and rising healthcare expenditures.
  • Latin America & Middle East & Africa: Emerging markets with growing investments in healthcare infrastructure.

Request customization on the report @ https://www.emergenresearch.com/request-for-customization/3695

? Key Market Players

  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • Quest Diagnostics

 

? Recent Developments

  • Assam Agricultural University Develops ASF Rapid Detection Kit: The College of Veterinary Science at Assam Agricultural University has developed a rapid antigen detection kit for African Swine Fever, enabling swift detection in pig samples.
  • Quest Diagnostics to Launch Bird Flu Test: Quest Diagnostics plans to introduce a new test for H5N1 bird flu, enhancing preparedness for potential outbreaks.
  • Oxford Nanopore Collaborates with NHS: Oxford Nanopore Technologies is working with the NHS to enhance pathogen screening, aiming to establish an early-warning system for future pandemics.

 

Posted in Default Category 4 days, 3 hours ago
Comments (0)
No login
gif
color_lens
Login or register to post your comment